Researchers have developed drug-delivering aptamers that can deliver a cytotoxic double punch to leukemic stem cells.

At the core of AI’s value in cancer care is its performance in early detection and diagnostic support, where deep learning ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

Study findings suggested that assessing ctDNA levels was as good or better at predicting recurrence than experimental tests ...

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study ...

A cancer-causing protein long thought to be resistant to medication could soon be the target of new drugs, thanks to the work ...

Discover the growth rates of 5 different skin cancers, from slow-developing basal cell carcinomas to aggressive melanomas, ...

The firm is developing a kitted version of the four-biomarker combination test, and it plans to commercialize them in the EU and US markets.

The following is a summary of "Potential changes in microorganisms and metabolites associated with oral cancer: a preliminary study," published in the April 2025 issue of BMC Cancer by Wei et al. Oral ...

The researchers concluded that slower turnaround time for biomarker testing is associated with early non-targeted treatment in patients with ALK +/ EGFR + advanced NSCLC, a practice that is “common,” ...

New indications discovered by applying active machine learning and using samples from the company’s vast biobank of live-cell tumors ...